Your browser doesn't support javascript.
loading
Combining BRAF inhibition with oncolytic herpes simplex virus enhances the immune-mediated antitumor therapy of BRAF-mutant thyroid cancer.
Crespo-Rodriguez, Eva; Bergerhoff, Katharina; Bozhanova, Galabina; Foo, Shane; Patin, Emmanuel C; Whittock, Harriet; Buus, Richard; Haider, Syed; Muirhead, Gareth; Thway, Khin; Newbold, Kate; Coffin, Robert S; Vile, Richard G; Kim, Dae; McLaughlin, Martin; Melcher, Alan A; Harrington, Kevin J; Pedersen, Malin.
Affiliation
  • Crespo-Rodriguez E; Targeted Therapy Team, The Institute of Cancer Research, London, United Kingdom.
  • Bergerhoff K; Targeted Therapy Team, The Institute of Cancer Research, London, United Kingdom.
  • Bozhanova G; Translational Immunotherapy Team, The Institute of Cancer Research, London, United Kingdom.
  • Foo S; Translational Immunotherapy Team, The Institute of Cancer Research, London, United Kingdom.
  • Patin EC; Targeted Therapy Team, The Institute of Cancer Research, London, United Kingdom.
  • Whittock H; Targeted Therapy Team, The Institute of Cancer Research, London, United Kingdom.
  • Buus R; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.
  • Haider S; Ralph Lauren Centre for Breast Cancer Research, Royal Marsden Hospital, London, United Kingdom.
  • Muirhead G; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.
  • Thway K; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.
  • Newbold K; Sarcoma Unit, The Royal Marsden Hospital, London, United Kingdom.
  • Coffin RS; Head and Neck/Thyroid Oncology Department, The Royal Marsden Hospital, London, United Kingdom.
  • Vile RG; Replimune Inc, Woburn, Massachusetts, United States.
  • Kim D; Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota, United States.
  • McLaughlin M; Head and Neck Department, St George's University Hospital, London, United Kingdom.
  • Melcher AA; Targeted Therapy Team, The Institute of Cancer Research, London, United Kingdom.
  • Harrington KJ; Translational Immunotherapy Team, The Institute of Cancer Research, London, United Kingdom.
  • Pedersen M; Targeted Therapy Team, The Institute of Cancer Research, London, United Kingdom.
J Immunother Cancer ; 8(2)2020 08.
Article in En | MEDLINE | ID: mdl-32759235
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thyroid Neoplasms / Proto-Oncogene Proteins B-raf / Oncolytic Virotherapy Limits: Animals / Female / Humans / Male Language: En Journal: J Immunother Cancer Year: 2020 Type: Article Affiliation country: United kingdom
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thyroid Neoplasms / Proto-Oncogene Proteins B-raf / Oncolytic Virotherapy Limits: Animals / Female / Humans / Male Language: En Journal: J Immunother Cancer Year: 2020 Type: Article Affiliation country: United kingdom